跳至主要内容
临床试验/CTRI/2021/01/030645
CTRI/2021/01/030645尚未招募未知

Comparative Efficacy of 2mg and 5mg Intrathecal Nalbuphine as an Adjuvant to Ropivacaine in Elective Lower Limb Surgeries

Veer Surendra Sai institute of medical science and research0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • ASA grade 1&2
  • Planned for elective lower limb surgeries

排除标准

  • Pregnant patients
  • Patients with co morbidities like hypertension and diabetes
  • Patient having contraindications to SAB
  • Weight more than 100kg and less than 30kg
  • Patients receiving CNS depressant drugs
  • Patient having cardiac renal respiratory disease
  • H/o adverse reactions to Ropivacaine and Nalbuphine

研究者

发起方
Veer Surendra Sai institute of medical science and research

相似试验